These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 6169079)
1. Prostate antigen: a new potential marker for prostatic cancer. Wang MC; Papsidero LD; Kuriyama M; Valenzuela LA; Murphy GP; Chu TM Prostate; 1981; 2(1):89-96. PubMed ID: 6169079 [TBL] [Abstract][Full Text] [Related]
2. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens. Kuriyama M; Wang MC; Lee CL; Killian CS; Papsidero LD; Inaji H; Loor RM; Lin MF; Nishiura T; Slack NH; Murphy GP; Chu TM J Natl Cancer Inst; 1982 Jan; 68(1):99-105. PubMed ID: 6172628 [TBL] [Abstract][Full Text] [Related]
3. A prostate antigen in sera of prostatic cancer patients. Papsidero LD; Wang MC; Valenzuela LA; Murphy GP; Chu TM Cancer Res; 1980 Jul; 40(7):2428-32. PubMed ID: 7388802 [TBL] [Abstract][Full Text] [Related]
4. Do men with prostate abnormalities (prostatitis/benign prostatic hyperplasia/prostate cancer) develop immunity to spermatozoa or seminal plasma? Hoover P; Naz RK Int J Androl; 2012 Aug; 35(4):608-15. PubMed ID: 22321000 [TBL] [Abstract][Full Text] [Related]
5. [The nature of the antigenic restructuring of tumors of the human prostate]. Nikolaev AA Vopr Onkol; 1988; 34(9):1064-70. PubMed ID: 2460999 [TBL] [Abstract][Full Text] [Related]
6. [Purification and determination of human prostate specific antigen in the serum]. Ogawa Y; Morikawa J; Ohsawa R; Machida T; Miki M; Yanagisawa M Radioisotopes; 1984 May; 33(5):273-8. PubMed ID: 6206524 [TBL] [Abstract][Full Text] [Related]
7. Sustained, substantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario. Glenski WJ; Malek RS; Myrtle JF; Oesterling JE Mayo Clin Proc; 1992 Mar; 67(3):249-52. PubMed ID: 1372057 [TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker. Mulders TM; Bruning PF; Bonfrer JM Eur J Surg Oncol; 1990 Feb; 16(1):37-41. PubMed ID: 1689677 [TBL] [Abstract][Full Text] [Related]
9. Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex. Sinha AA; Wilson MJ; Gleason DF Cancer; 1987 Sep; 60(6):1288-93. PubMed ID: 2441840 [TBL] [Abstract][Full Text] [Related]
10. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Kuriyama M; Wang MC; Papsidero LD; Killian CS; Shimano T; Valenzuela L; Nishiura T; Murphy GP; Chu TM Cancer Res; 1980 Dec; 40(12):4658-62. PubMed ID: 6159971 [TBL] [Abstract][Full Text] [Related]
11. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma]. Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496 [TBL] [Abstract][Full Text] [Related]
12. Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia. Pretlow TG; Pretlow TP; Yang B; Kaetzel CS; Delmoro CM; Kamis SM; Bodner DR; Kursh E; Resnick MI; Bradley EL Int J Cancer; 1991 Nov; 49(5):645-9. PubMed ID: 1718912 [TBL] [Abstract][Full Text] [Related]
13. Purification of a human prostate specific antigen. Wang MC; Valenzuela LA; Murphy GP; Chu TM Invest Urol; 1979 Sep; 17(2):159-63. PubMed ID: 89106 [TBL] [Abstract][Full Text] [Related]
14. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720 [TBL] [Abstract][Full Text] [Related]
15. Prostate specific antigen. Experimental and clinical observations. Huber PR; Schnell Y; Hering F; Rutishauser G Scand J Urol Nephrol Suppl; 1987; 104():33-9. PubMed ID: 2449722 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody to the prostate specific antigen. Donn F; Bruns T; von Meyerrinck L; Augustin C; Schulz M; Klosterhalfen H; Schmoldt A Andrologia; 1990; 22 Suppl 1():44-55. PubMed ID: 1720289 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody (anti-Leu 7) directed against natural killer cells reacts with normal, benign and malignant prostate tissues. Wahab ZA; Wright GL Int J Cancer; 1985 Dec; 36(6):677-83. PubMed ID: 2415469 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen. Purnell DM; Heatfield BM; Trump BF Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163 [TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors]. Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809 [No Abstract] [Full Text] [Related]
20. [Tumor associated markers as organ-specific antigens of the human seminal plasma. II. Immunohistological studies]. Dienst C; Uhlenbruck G; Heising J; Höller U; Dreessen C Z Hautkr; 1985 Jan; 60(1-2):157-64. PubMed ID: 2580399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]